In vivo 19F Magnetic Resonance Spectroscopy and Chemical Shift Imaging of Tri-Fluoro-Nitroimidazole as a Potential Hypoxia Reporter in Solid Tumors
Open Access
- 15 June 2007
- journal article
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 13 (12) , 3738-3747
Abstract
Purpose: 2-Nitro-α-[(2,2,2-trifluoroethoxy)methyl]-imidazole-1-ethanol (TF-MISO) was investigated as a potential noninvasive marker of tissue oxygen levels in tumors using 19F magnetic resonance spectroscopy (MRS) and 19F chemical shift imaging.Keywords
This publication has 32 references indexed in Scilit:
- In vivo31P MR spectral patterns and reproducibility in cancer patients studied in a multi‐institutional trialNMR in Biomedicine, 2006
- Utility of 19F MRS detection of the hypoxic cell marker EF5 to assess cellular hypoxia in solid tumorsRadiotherapy and Oncology, 2004
- Current issues in the utility of 19 F nuclear magnetic resonance methodologies for the assessment of tumour hypoxiaPhilosophical Transactions of the Royal Society B: Biological Sciences, 2004
- Hypoxia — a key regulatory factor in tumour growthNature Reviews Cancer, 2002
- A new perfluorocarbon for use in fluorine‐19 magnetic resonance imaging and spectroscopyMagnetic Resonance in Medicine, 1993
- Development of an in vivo19F magnetic resonance method for measuring oxygen deficency in tumorsMagnetic Resonance in Medicine, 1991
- Essential considerations for spectral localization using indirect gradient encoding of spatial informationJournal of Magnetic Resonance (1969), 1991
- In vivo19f spin relaxation in index finger bonesMagnetic Resonance in Medicine, 1990
- Metabolism and toxicity of 2,2,2-trifluoroethyl vinyl ether.Environmental Health Perspectives, 1977
- Oxygen inhibition of nitroreductase: Electron transfer from nitro radical-anions to oxygenBiochemical and Biophysical Research Communications, 1976